Effect of BI 1356 as Single Dose on the QT Interval in Healthy Female and Male Subjects
Clinical trial NCT02183467 · COMPLETED
Trial details
- NCT number
- NCT02183467
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2008-06-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.